Data / Form D filings / Leafline Labs, LLC
Leafline Labs, LLC: Form D filings
Leafline Labs, LLC, a pharmaceuticals company in Cottage Grove, MN, filed 3 Form D notices with the SEC between 2014 and 2016. The latest, on May 9, 2016, reports $149,600 sold of a $21 million offering to 1 investor.
Find out what Leafline Labs, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8235 97th Street South, Cottage Grove, MN, 55016
- Phone
- (844) 532-3546
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Minnesota
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1621013
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 9, 2016 | New notice | $21,000,000 | $149,600 | $20,850,400 | 1 | Jan 25, 2016 | sec.gov |
| Oct 30, 2015 | Amendment | $15,125,000 | $14,948,643 | $176,357 | 141 | Dec 1, 2014 | sec.gov |
| Dec 4, 2014 | New notice | $15,125,000 | $12,399,200 | $2,725,800 | 113 | Dec 1, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary Starr | Promoter | |
| Peter Bachman | Promoter | |
| Mark Bachman | Promoter | |
| Paul Bachman | Promoter | |
| Kelly Henry | Promoter | |
| Glenn Taylor | Director, Promoter | |
| Mitchell Baruchowitz | Director, Promoter | |
| Andrew Bachman | Executive Officer, Director, Promoter | |
| Ethan Ruby | Director, Promoter | |
| Colin Kelley | Executive Officer | |
| Tara Mulloy | Executive Officer |
Every Form D from the week of May 9, 2016 · All recent filings in Minnesota · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Leafline Labs, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.